The balance of benefit and safety of rosiglitazone: important lessons for our system of drug development and postmarketing assessment.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Califf, RM; Kramer, JM

Published Date

  • August 2008

Published In

Volume / Issue

  • 17 / 8

Start / End Page

  • 782 - 786

PubMed ID

  • 18655016

Pubmed Central ID

  • 18655016

Electronic International Standard Serial Number (EISSN)

  • 1099-1557

Digital Object Identifier (DOI)

  • 10.1002/pds.1617

Language

  • eng

Conference Location

  • England